📷 Image: Wikimedia Commons / Unknown authorUnknown author
Health
CDSCO finds all 199 drug samples substandard, one counterfeit, raising efficacy concerns
✍️ Amar Ujala
🗓 07 Sep 2026, 07:32 AM
👁 5
In a recent quality check, the Central Drugs Standard Control Organization reported that none of the 199 medicine samples met standards, with one confirmed counterfeit, prompting doubts over drug effectiveness.
The Central Drugs Standard Control Organization (CDSCO) has disclosed the results of a quality assessment involving 199 medicine samples collected from various sources. According to the agency, every sample failed to meet the prescribed quality benchmarks, indicating widespread non‑compliance.
Among the failed batches, laboratory analysis identified one sample as a counterfeit product, confirming the presence of deliberately falsified medication in the market. The discovery underscores the risk that substandard or fake drugs pose to patient safety and therapeutic outcomes.
Health officials have warned that the failure of such a large number of samples raises serious concerns about the efficacy of many medicines currently in circulation. The CDSCO has said it will intensify surveillance, recall compromised batches, and pursue legal action against responsible parties to safeguard public health.
Among the failed batches, laboratory analysis identified one sample as a counterfeit product, confirming the presence of deliberately falsified medication in the market. The discovery underscores the risk that substandard or fake drugs pose to patient safety and therapeutic outcomes.
Health officials have warned that the failure of such a large number of samples raises serious concerns about the efficacy of many medicines currently in circulation. The CDSCO has said it will intensify surveillance, recall compromised batches, and pursue legal action against responsible parties to safeguard public health.